Cloopen Group Holding Limited Sponsored ADR RAAS
1.13
0.00
0.00%
as of 11 Jun
- Market cap
- $121.2M
- P/E
- 0.0×
Follow RAAS
| Dec '21 | Sep '21 | Jun '21 | Mar '21 | Older periods | |
|---|---|---|---|---|---|
| 505.37% | (426.60%) | (424.91%) | — |
+3 more TTM periods Free account |
|
| (291.16%) | (164.28%) | (167.77%) | — | ||
ROIC |
0.00% | (16.98%) | 0.00% | 0.00% | |
Return on Tangible Assets |
(285.64%) | (118.09%) | (132.80%) | 0.00% | |
Average Days of Receivables |
77.12 | 133.19 | 149.46 | 0.00 | |
Free Cash Flow per Share |
(2.03) | 0.00 | 0.00 | 0.00 | |
Free Cash Flow |
(99.61) | — | — | — | |
Capital Expenditures |
(3.40) | — | — | — | |
Piotroski F-Score |
1.00 | 0.00 | 0.00 | — | |
| Other line items | |||||
Cash ROIC |
(13.01%) | 0.00% | 0.00% | 0.00% | |
Accounts Receivable Turnover |
3.78 | 3.40 | 3.12 | — | |
Accounts Payable Turnover |
3.48 | 3.91 | 3.73 | — | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | — | |
Average Days of Payables |
112.38 | 112.56 | 97.79 | 0.00 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | — | |
Tax Rate |
0.01 | (0.03) | 0.00 | — | |
Research and Development Expense of Revenue |
39.51% | 25.42% | 22.68% | — | |
Selling, General and Administrative Expense of Revenue |
91.08% | 60.00% | 61.67% | — | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | — | |
Interest Coverage |
0.00 | 0.00 | — | — | |
Operating CF/Net income |
0.11 | 0.00 | 0.00 | — | |
Depreciation/Fixed assets |
1.89 | 0.00 | 0.00 | 0.00 | |
Capex/Depreciation |
(0.81) | — | — | — | |
Revenue per Share |
2.40 | 2.71 | 2.56 | 0.00 | |
Operating CF per Share |
(1.96) | 0.00 | 0.00 | 0.00 | |
Capex per Share |
(0.07) | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.03 | 0.00 | 0.00 | — | |
Net Profit Margin |
(768.25%) | (326.60%) | (381.99%) | — |
Columns are period end dates